Nu Skin Enterprises, Inc.
NUS · Price history
Price at last available close
$4.73
+$0.09 (+1.94%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Nu Skin Enterprises, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products.
How they make money
Nu Skin operates in the direct selling channel, primarily utilizing person-to-person marketing to promote and sell beauty and wellness products through a network of independent affiliates. The company also operates Rhyz Inc., a strategic investment arm that manages a portfolio of consumer, technology, and manufacturing companies to explore synergistic growth.
Products & services
Premium-quality beauty and wellness products, including anti-aging skincare and nutritional supplements, marketed primarily under the Nu Skin, Pharmanex, and ageLOC brands.
Brands & revenue mix
Core brand for beauty and personal care products.
Separate brand revenue is not available in this research.Source
Brand focused on nutritional supplements and wellness products.
Separate brand revenue is not available in this research.Source
Anti-aging product line integrated across beauty and wellness categories.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
The company does not rely on any single customer for a material portion of its revenue, as its business model is based on a large network of independent affiliates and individual consumers.
Suppliers, materials & equipment
- Contract Manufacturers — The company utilizes various third-party contract manufacturers to produce its beauty and wellness products.Source
Competitors
- Direct Selling Companies — Other companies operating within the direct selling and multi-level marketing industry that compete for the same pool of independent distributors and consumers.Source
- Traditional Retail Beauty and Wellness Brands — Companies selling beauty and personal care products through traditional retail channels, including department stores, drugstores, and e-commerce platforms.Source
Strengths
Sources
Financial risk observations and what to check
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.
Quarterly EPS turned negative at -5.14 versus 0.43 a year earlier.
Separate recurring operating losses from noncash or one-time charges, and check cash flow rather than interpreting negative EPS as a cash-outflow amount.
Quarterly net income turned from a profit to a loss versus the same quarter last year.
Identify the causes in the interim report and distinguish operating cash use from accounting charges. Prior profitability is not a guarantee of recovery.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
30
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
39
Poor
Financial Strength
71
Business Quality / Moat
14
Management
44
Growth Quality
9
Risk / Durability
48
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
26
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
36/100
Building Historical Record
Model Score 36/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Recent buyback activity is present
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for NUS
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving NUS's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •Is NUS's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Does NUS's balance between cash and debt leave enough flexibility if business conditions weaken?
- •What specifically needs to improve for NUS to reach sustainable profitability?
- •What future growth or profitability would be needed to justify NUS's current valuation?
Essential Investment Snapshot
Wall Street Score
30
Opportunity Score
26
Market Cap
$230.2M
P/E Ratio
-1.1
EPS
$-4.45
52-Week High
$11.67
52-Week Low
$4.45
Beta
0.90
Analyst Target
$11.00
Shares Outstanding
50.3M
Total Revenue
$1.38B
Total Debt
$263.7M
Dividend Yield (TTM)
5.07%
Liquidation Value / Share
$10.79
Dividend / Share (TTM)
$0.24
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for NUS
Detected from reported data — verify before acting.Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on NUS.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Global direct selling infrastructure.
- +Established brand portfolio (Nu Skin, Pharmanex, ageLOC).
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Household & Personal Products industry.
- −Dependence on the effectiveness of the direct selling business model.
- −Regulatory risks associated with direct selling and multi-level marketing laws.
- −Foreign currency exchange rate fluctuations.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
3 historical score records availablePrevious Score
30
Oct 1, 2026
Change
Unchanged
Current Score
30
Oct 8, 2026
Category Changes
NUS score was unchanged.
Projected Score
Projected Score
21
Projected Change
-9.5 points
Preliminary comparable-period financial changes suggest decline of approximately 9.5 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$4.73
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.49B | $1.73B | $1.97B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $423.8M | $453.8M | $550.2M | $611.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $951.5M | $1.03B | $1.18B | $1.36B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $10.8M | $0.00 | $13.0M | $22.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $881.2M | $940.5M | $1.13B | $1.29B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $960.1M | $940.5M | $1.33B | $1.31B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $39.3M | $262.4M | -$78.8M | $204.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$8.6M | $90.9M | -$151.6M | $48.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $15.7M | $13.9M | $26.4M | $25.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$26.4M | $196.2M | -$175.1M | $26.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $190.0M | $36.0M | -$28.5M | $18.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$216.4M | $160.2M | -$146.6M | $8.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-4.45 | $3.25 | $-2.95 | $0.17 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 48.60M | 49.29M | 49.66M | 49.71M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 48.60M | 50.30M | 49.66M | 49.86M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$320.1M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$5.14
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-15.1%
Cash Change
-28.2%
Margin Change
-83.5 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Debt reduced
What Weakened
- Margins contracted
- Cash position declined
Potential Score Impact
Positive indicators included debt levels. Pressure indicators included revenue growth, EPS growth, cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 17.1%. EPS declined 1295.3%. Cash declined 28.2%. Total debt declined 15.1%. Net income margin declined by 83.5 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Log in to view dividend history.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
3 historical recordsHistorical Score Chart
3 of 3 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Household & Personal ProductsNews
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push
STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore
Rumor Mill · NUS
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial